Drug Delivery Markets, Vol I: Oral Delivery

Table of Contents

Chapter one: Executive Summary

• Market Drivers
• Market Size and Growth
  • Total Oral Drug Delivery Market
  • Oral Drug Delivery Technology Only Market
• Competitive and Market Analysis

Chapter two: Introduction and Overview

• Scope of the Report
• Methodology
• History of Oral Drug Delivery
• Phases of Drug Action
• Barriers to Oral Drug Delivery
• Controlled-Release/Sustained-Release
• Delayed Release and Modified Release
• Fast Dissolving
• Taste-Masked
• Pulsatile Release
• Microemulsion and Others

Chapter three: Key Trends and Demographics

• The Elderly
• Regulatory Environment
• Patent Protection and Extension
• Earlier Involvement
• Consolidation
• Proprietary Product Development
• Implications for Generic and Over-the-Counter Products
• Pharmaceutical Formulation

Chapter four: New Developments

• Macromolecule Delivery
• Delivery of Hydrophobic Drugs
• Other Delivery Solutions

Chapter five: Market Size and Growth

• The Total Oral Drug Delivery Market
• Oral Delivery Technology Only Market

Chapter six: Competitive Analysis

• Competitive Landscape

Chapter seven: Company Profiles

• ALZA Corporation
• Andrx Pharmaceuticals
• Biovail Corporation
• Cardinal Health
• Elan Corporation, plc
• Emisphere Technologies, Inc.
• KV Pharmaceutical
• Labopharm, Inc.
• Penwest Pharmaceutical Company
• Purdue/MundiPharma/Napp Group
• SkyePharma PLC

Chapter eight: Companies in Brief

• Alkermes, Inc.
• Astellas
• BioProgress Technologies International, Inc.
• CIMA Labs, Inc. Division of Cephalon
• DepoMed, Inc.
• Endorex, Inc.
• Eurand, Inc.
• Kos Pharmaceuticals, Inc.
• Lipocine, Inc.

Appendix: Company Directory

List of Exhibits

Chapter one: Executive Summary

Chapter two: Introduction and Overview

• Table 2-1: Selected Types of Oral Solid Preparations
• Table 2-2: Sequence of Drug Action

Chapter three: Key Trends and Demographics

• Table 3-1: World Population by Age Group 2002-2010
• Figure 3-1: World Population by Age Group 2002-2010
• Table 3-2: Recent Consolidations in the Drug Delivery Market

Chapter four: New Developments

Chapter five: Market Size and Growth

• Table 5-1: The Worldwide Market for Oral Drug Delivery Technology and Pharmaceuticals Revenues and Growth Rate 2002-2010
• Figure 5-1: Trending in the Worldwide Market for Oral Drug Delivery Technology and Pharmaceuticals 2002-2010
• Table 5-2: The Worldwide Market for Pharmaceuticals Utilizing Oral Drug Delivery Technologies by Type 2002-2010
• Figure 5-2: Trending in the Worldwide Market for Pharmaceuticals Utilizing Oral Drug Delivery Technologies by Type 2002-2010
• Table 5-3: The Worldwide Market for Pharmaceuticals Utilizing Oral Drug Market Share by Type 2002-2010
• Table 5-4: The Worldwide Market for Oral Drug Delivery Systems by Pharmaceutical vs Drug Delivery Components 2002-2010
• Table 5-5: The Worldwide Market for Oral Drug Delivery Systems Distribution of Revenue by Pharmaceutical vs Drug Delivery Component 2002-2010
• Figure 5-3: The Worldwide Market for Oral Drug Delivery Systems Share of Revenue by Pharmaceutical and Drug Delivery Component 2006, 2010

Chapter six: Competitive Analysis

• Table 6-1: Leading Suppliers of Oral Drug Delivery Technology (Company, Proprietary Technology, Approved Products)